NCT01429831View on ClinicalTrials.gov

Aripiprazole for the Augmentation of Antidepressant Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Major Depressive Disorder
Interventions
DRUG

Aripiprazole

starting aripiprazole dose from 2-5mg/day, dose adjustment by every week, and maximum dose can up to 15mg/day. The duration is 6 weeks.

Trial Locations (1)

Unknown

Chung Shan Medical University Hospital, Taichung

All Listed Sponsors
lead

Taiwan Otsuka Pharm. Co., Ltd

INDUSTRY

NCT01429831 - Aripiprazole for the Augmentation of Antidepressant Therapy | Biotech Hunter | Biotech Hunter